{"transactions":[{"id":709078,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-15T23:03:13.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4418,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Common Stock (a \"Company Stock Option\") that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the effective time of the Merger and (y) the excess, if any, of the Offer Price over the applicable exercise price per share under such Company Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Common Stock (a \"Company Stock Option\") that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the effective time of the Merger and (y) the excess, if any, of the Offer Price over the applicable exercise price per share under such Company Stock Option."}],"balance_after":0,"derivative":{"exercise_price":105.74,"expiration_date":"2035-12-10","underlying":"Class A Common Stock","underlying_shares":4418},"source":{"system":"sec-edgar","filing":"0001193125-26-305080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526305080/ownership.xml","form_type":"4"}},{"id":709077,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock - Restricted Stock Units","published_at":"2026-07-15T23:03:13.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6281,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) Nuvalent, Inc., a Delaware corporation (the \"Company\"), (ii) GlaxoSmithKline LLC, a Delaware limited liability company (\"Parent\"), (iii) Harmony Row Acquisition Co., a Delaware corporation and wholly owned subsidiary of Parent (\"Purchaser\"), and (iv) solely for purposes of Section 9.14 therein, GSK plc, a public limited company organized under the laws of England and Wales (\"Ultimate Parent\"), Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of Class A Common Stock of the Company and Class B Common Stock of the Company. The shares of Class A Common Stock of the Company and Class B Common Stock of the Company that were tendered to Purchaser prior to the expiration time of the offer were exchanged for $124.00 per share, net to the seller in cash, without interest (the \"Offer Price\"),"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) subject to applicable withholding tax. After completion of the Offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, each restricted stock unit that was subject solely to time-based vesting (a \"Company RSU\") that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such Company RSU immediately prior to the effective time of the Merger and (y) the Offer Price."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, each restricted stock unit that was subject solely to time-based vesting (a \"Company RSU\") that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such Company RSU immediately prior to the effective time of the Merger and (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each restricted stock unit that was subject solely to time-based vesting (a \"Company RSU\") that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such Company RSU immediately prior to the effective time of the Merger and (y) the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-305080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526305080/ownership.xml","form_type":"4"}},{"id":732251,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:34:46.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":3444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date."}],"balance_after":6281,"source":{"system":"sec-edgar","filing":"0001454001-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861560/000145400126000004/ownership.xml","form_type":"4"}},{"id":751583,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:03:29.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":15196,"price":3.08,"value":46803.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":123431,"source":{"system":"sec-edgar","filing":"0001628280-26-040492","document":"wk-form4_1780520606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000162828026040492/wk-form4_1780520606.xml","form_type":"4"}},{"id":751582,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:03:29.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer.  Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":138627,"source":{"system":"sec-edgar","filing":"0001628280-26-040492","document":"wk-form4_1780520606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000162828026040492/wk-form4_1780520606.xml","form_type":"4"}},{"id":767847,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-21T21:00:22.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":12000,"derivative":{"exercise_price":42.26,"exercise_date":"2027-05-19","expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001454001-26-000002","document":"form4-05212026_050515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000145400126000002/form4-05212026_050515.xml","form_type":"4"}},{"id":767846,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T21:00:22.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":39375,"source":{"system":"sec-edgar","filing":"0001454001-26-000002","document":"form4-05212026_050515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000145400126000002/form4-05212026_050515.xml","form_type":"4"}},{"id":972752,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-11T21:31:14.000Z","date":"2025-12-10","kind":"grant","planned":false,"acquired":true,"shares":4418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest over the three years following December 10, 2025, in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date."}],"balance_after":4418,"derivative":{"exercise_price":105.74,"expiration_date":"2035-12-10","underlying":"Class A Common Stock","underlying_shares":4418},"source":{"system":"sec-edgar","filing":"0001193125-25-316060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312525316060/ownership.xml","form_type":"4"}},{"id":972751,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-11T21:31:14.000Z","date":"2025-12-10","kind":"grant","planned":false,"acquired":true,"shares":2837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following December 10, 2025, subject to continued service to Nuvalent, Inc. through the applicable vesting date."}],"balance_after":2837,"source":{"system":"sec-edgar","filing":"0001193125-25-316060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312525316060/ownership.xml","form_type":"4"}},{"id":1107863,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-17T21:03:44.000Z","date":"2025-06-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":15184,"price":3.58,"value":54358.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":93627,"source":{"system":"sec-edgar","filing":"0001628280-25-031895","document":"wk-form4_1750194217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000162828025031895/wk-form4_1750194217.xml","form_type":"4"}},{"id":1121227,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-05T21:05:59.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's\ncontinued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":108811,"source":{"system":"sec-edgar","filing":"0001628280-25-029724","document":"wk-form4_1749157450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000162828025029724/wk-form4_1749157450.xml","form_type":"4"}},{"id":1145219,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-05-16T23:00:20.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":21.15,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-25-013503","document":"form4-05162025_070517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000141588925013503/form4-05162025_070517.xml","form_type":"4"}},{"id":1145218,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T23:00:20.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":35375,"source":{"system":"sec-edgar","filing":"0001415889-25-013503","document":"form4-05162025_070517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000141588925013503/form4-05162025_070517.xml","form_type":"4"}},{"id":1475120,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-19T01:35:24.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":6995,"price":2.89,"value":20215.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units."}],"balance_after":80663,"source":{"system":"sec-edgar","filing":"0001628280-24-028987","document":"wk-form4_1718760917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000162828024028987/wk-form4_1718760917.xml","form_type":"4"}},{"id":1478879,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-14T21:25:58.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\")  made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":87658,"source":{"system":"sec-edgar","filing":"0001628280-24-028343","document":"wk-form4_1718400349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000162828024028343/wk-form4_1718400349.xml","form_type":"4"}},{"id":1483363,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:34:18.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":14.46,"underlying":"Common Stock","underlying_shares":4727},"source":{"system":"sec-edgar","filing":"0000950170-24-072199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000095017024072199/ownership.xml","form_type":"4"}},{"id":1483362,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:34:18.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":14.91,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-072199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000095017024072199/ownership.xml","form_type":"4"}},{"id":1483361,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:34:18.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3269,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":21.27,"underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000950170-24-072199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000095017024072199/ownership.xml","form_type":"4"}},{"id":1483360,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:34:18.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":13.98,"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000950170-24-072199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000095017024072199/ownership.xml","form_type":"4"}},{"id":1483359,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:34:18.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9570,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":8.27,"underlying":"Common Stock","underlying_shares":9570},"source":{"system":"sec-edgar","filing":"0000950170-24-072199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000095017024072199/ownership.xml","form_type":"4"}},{"id":1520589,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-10T20:06:05.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":6.82,"exercise_date":"2025-05-08","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-24-012851","document":"form4-05102024_040553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000141588924012851/form4-05102024_040553.xml","form_type":"4"}},{"id":1520588,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T20:06:05.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":28875,"source":{"system":"sec-edgar","filing":"0001415889-24-012851","document":"form4-05102024_040553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000141588924012851/form4-05102024_040553.xml","form_type":"4"}},{"id":1676290,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T21:15:10.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":4727,"price":10.5783,"value":50003.6241,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2024 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2024 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":4727,"derivative":{"exercise_price":14.46,"expiration_date":"2034-01-15","underlying":"Common Stock","underlying_shares":4727},"source":{"system":"sec-edgar","filing":"0000950170-24-005386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000095017024005386/ownership.xml","form_type":"4"}},{"id":1845111,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T20:05:16.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 21, 2024, subject to continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":14.91,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-039329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919123039329/doc4.xml","form_type":"4"}},{"id":1884469,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-19T20:05:12.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":13500,"derivative":{"exercise_price":17.11,"exercise_date":"2024-05-17","expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-23-030950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919123030950/doc4.xml","form_type":"4"}},{"id":1884468,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:05:12.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":22375,"source":{"system":"sec-edgar","filing":"0001209191-23-030950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919123030950/doc4.xml","form_type":"4"}},{"id":2050780,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T21:05:35.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":3269,"price":15.2952,"value":50000.0088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2023 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2023 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":3269,"derivative":{"exercise_price":21.27,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0001209191-23-003993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919123003993/doc4.xml","form_type":"4"}},{"id":2221980,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:05:46.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2023, subject to continued service through such date."}],"balance_after":18500,"derivative":{"exercise_price":13.98,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-039198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919122039198/doc4.xml","form_type":"4"}},{"id":2273462,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-13T00:40:36.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":21.38,"exercise_date":"2023-05-11","expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-028703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919122028703/doc4.xml","form_type":"4"}},{"id":2273461,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T00:40:36.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":17875,"source":{"system":"sec-edgar","filing":"0001209191-22-028703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919122028703/doc4.xml","form_type":"4"}},{"id":2430317,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:01:06.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":9570,"price":5.22,"value":49955.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2022 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy.  2,393 shares will vest on March 31, 2022, 2,393 shares will vest on June 30, 2022, 2,393 shares will vest on September 30, 2022 and the remaining 2,391 shares will vest on December 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2022 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy.  2,393 shares will vest on March 31, 2022, 2,393 shares will vest on June 30, 2022, 2,393 shares will vest on September 30, 2022 and the remaining 2,391 shares will vest on December 31, 2022."}],"balance_after":9570,"derivative":{"exercise_price":8.27,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":9570},"source":{"system":"sec-edgar","filing":"0001209191-22-004082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919122004082/doc4.xml","form_type":"4"}},{"id":2654689,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T20:00:31.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 23, 2022, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":35.86,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-043272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919121043272/doc4.xml","form_type":"4"}},{"id":2707854,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-19T01:11:27.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":18.27,"exercise_date":"2022-05-14","expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-033845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919121033845/doc4.xml","form_type":"4"}},{"id":2707853,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T01:11:27.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":14875,"source":{"system":"sec-edgar","filing":"0001209191-21-033845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919121033845/doc4.xml","form_type":"4"}},{"id":2902247,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T21:00:07.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":1563,"price":31.99,"value":50000.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2021 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy.  391 shares will vest on March 31, 2021, 391 shares will vest on June 30, 2021, 391 shares will vest on September 30, 2021 and the remaining 390 shares will vest on December 31, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2021 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy.  391 shares will vest on March 31, 2021, 391 shares will vest on June 30, 2021, 391 shares will vest on September 30, 2021 and the remaining 390 shares will vest on December 31, 2021."}],"balance_after":1563,"derivative":{"exercise_price":50.07,"expiration_date":"2031-01-14","underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-004247","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919121004247/doc4.xml","form_type":"4"}},{"id":3080420,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-17T20:00:19.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":723,"price":34.58,"value":25001.34,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee for the second half of 2020 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy and 362 shares will vest on September 30, 2020 and 361 shares will vest on December 31, 2020, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company."}],"balance_after":723,"derivative":{"exercise_price":53.41,"expiration_date":"2030-07-15","underlying":"Common Stock","underlying_shares":723},"source":{"system":"sec-edgar","filing":"0001209191-20-042771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919120042771/doc4.xml","form_type":"4"}},{"id":3111796,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:00:19.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 10, 2021, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":56.46,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-036236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919120036236/doc4.xml","form_type":"4"}},{"id":3142594,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2020-05-20T00:00:23.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":15.43,"exercise_date":"2021-05-15","expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-030750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919120030750/doc4.xml","form_type":"4"}},{"id":3142593,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T00:00:23.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11875,"source":{"system":"sec-edgar","filing":"0001209191-20-030750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919120030750/doc4.xml","form_type":"4"}},{"id":3259476,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-20T21:05:15.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":21900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option will vest in equal monthly installments over a three-year period, subject to a continued service relationship through such dates."}],"balance_after":21900,"derivative":{"exercise_price":51.85,"expiration_date":"2029-12-03","underlying":"Common Stock","underlying_shares":21900},"source":{"system":"sec-edgar","filing":"0001209191-20-011032","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919120011032/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-06"}},{"id":3349695,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-06T21:09:13.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option will vest in equal monthly installments over a three-year period, subject to a continued service relationship through such dates."}],"balance_after":24000,"derivative":{"exercise_price":51.85,"expiration_date":"2029-12-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-19-059467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919119059467/doc4.xml","form_type":"4"}},{"id":3453520,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":678750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option provided for vesting in four equal annual installments beginning on December 16, 2019."}],"balance_after":0,"derivative":{"exercise_price":15.97,"expiration_date":"2028-12-16","underlying":"Common Stock","underlying_shares":678750},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453519,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option provided for vesting in four equal annual installments beginning on December 16, 2018."}],"balance_after":0,"derivative":{"exercise_price":10.92,"expiration_date":"2027-12-16","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453518,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":421875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option provided for vesting in four equal annual installments beginning on December 26, 2017."}],"balance_after":0,"derivative":{"exercise_price":8.79,"expiration_date":"2026-12-27","underlying":"Common Stock","underlying_shares":421875},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453517,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":453750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option provided for vesting in four equal annual installments beginning on April 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2026-04-01","underlying":"Common Stock","underlying_shares":453750},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453516,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":113438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option provided for vesting in four equal annual installments beginning on April 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":7.3,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":113438},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453515,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":345312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option provided for vesting in four equal annual installments beginning on April 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":4.63,"expiration_date":"2024-04-01","underlying":"Common Stock","underlying_shares":345312},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453514,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":545820,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting in four equal annual installments beginning on April 26, 2013."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2022-04-26","underlying":"Common Stock","underlying_shares":545820},"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453513,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":442190,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Company common stock underlying each restricted stock unit (a \"Company RSU\") held by the Reporting Person, whether or not vested. Pursuant to the terms of the Merger Agreement, each Company RSU held by the Reporting Person was converted into the right to receive an amount in cash equal to the product of (i) $48.00 and (ii) the number of shares of Company common stock subject to such Company RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3453512,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-07-30T20:06:01.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":259891,"price":48,"value":12474768.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."}],"balance_after":442190,"source":{"system":"sec-edgar","filing":"0001209191-19-043786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043786/doc4.xml","form_type":"4"}},{"id":3531484,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2019-05-11T00:38:38.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":17.94,"exercise_date":"2020-05-08","expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-029159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919119029159/doc4.xml","form_type":"4"}},{"id":3531483,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-11T00:38:38.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8875,"source":{"system":"sec-edgar","filing":"0001209191-19-029159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919119029159/doc4.xml","form_type":"4"}},{"id":3565845,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2019-04-03T16:31:02.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":18906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016."}],"balance_after":18907,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18906},"source":{"system":"sec-edgar","filing":"0001562180-19-002183","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002183/primarydocument.xml","form_type":"4"}},{"id":3565844,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2019-04-03T16:31:02.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":18907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18907},"source":{"system":"sec-edgar","filing":"0001562180-19-002183","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002183/primarydocument.xml","form_type":"4"}},{"id":3565843,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-04-03T16:31:02.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":16631,"price":24.6,"value":409122.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":259891,"source":{"system":"sec-edgar","filing":"0001562180-19-002183","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002183/primarydocument.xml","form_type":"4"}},{"id":3565842,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-04-03T16:31:02.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":37813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted on April 1, 2015 and April 1, 2016, as a result of the vesting of one fourth of such RSUs."}],"balance_after":276522,"source":{"system":"sec-edgar","filing":"0001562180-19-002183","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002183/primarydocument.xml","form_type":"4"}},{"id":3668757,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-08T18:31:32.000Z","date":"2019-02-07","kind":"exercise","acquired":false,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal annual installments beginning on April 26, 2013."}],"balance_after":545820,"derivative":{"exercise_price":3.61,"expiration_date":"2022-04-26","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001562180-19-000859","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000859/primarydocument.xml","form_type":"4"}},{"id":3668756,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-08T18:31:32.000Z","date":"2019-02-07","kind":"sale","acquired":false,"shares":110000,"price":21.6365,"value":2380015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $21.50 to $21.80. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":238709,"source":{"system":"sec-edgar","filing":"0001562180-19-000859","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000859/primarydocument.xml","form_type":"4"}},{"id":3668755,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-08T18:31:32.000Z","date":"2019-02-07","kind":"exercise","acquired":true,"shares":110000,"price":3.61,"value":397100.0,"ownership":{"direct":true},"balance_after":348709,"source":{"system":"sec-edgar","filing":"0001562180-19-000859","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000859/primarydocument.xml","form_type":"4"}},{"id":3679875,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-01T20:44:10.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":113438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in four equal annual installments beginning on April 1, 2016."}],"balance_after":113438,"derivative":{"exercise_price":7.3,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":113438},"source":{"system":"sec-edgar","filing":"0001562180-19-000687","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000687/primarydocument.xml","form_type":"4"}},{"id":3679874,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-01T20:44:10.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal annual installments beginning on April 26, 2013."}],"balance_after":655820,"derivative":{"exercise_price":3.61,"expiration_date":"2022-04-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-19-000687","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000687/primarydocument.xml","form_type":"4"}},{"id":3679873,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-01T20:44:10.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":113438,"price":18.5259,"value":2101541.0442,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $18.50 to $18.605. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":238709,"source":{"system":"sec-edgar","filing":"0001562180-19-000687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000687/primarydocument.xml","form_type":"4"}},{"id":3679872,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-01T20:44:10.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":113438,"price":7.3,"value":828097.4,"ownership":{"direct":true},"balance_after":352147,"source":{"system":"sec-edgar","filing":"0001562180-19-000687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000687/primarydocument.xml","form_type":"4"}},{"id":3679871,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-01T20:44:10.000Z","date":"2019-01-30","kind":"sale","acquired":false,"shares":100000,"price":18.2537,"value":1825370.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $18.25 to $18.29. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":238709,"source":{"system":"sec-edgar","filing":"0001562180-19-000687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000687/primarydocument.xml","form_type":"4"}},{"id":3679870,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-01T20:44:10.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":100000,"price":3.61,"value":361000.0,"ownership":{"direct":true},"balance_after":338709,"source":{"system":"sec-edgar","filing":"0001562180-19-000687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000687/primarydocument.xml","form_type":"4"}},{"id":3727426,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:48:29.000Z","date":"2018-12-16","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested and were settled in common stock on December 16, 2018."}],"balance_after":75000,"derivative":{"exercise_price":0,"expiration_date":"2021-12-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-005027","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005027/primarydocument.xml","form_type":"4"}},{"id":3727425,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:48:29.000Z","date":"2018-12-16","kind":"exercise","acquired":false,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested and were settled in common stock on December 16, 2018."}],"balance_after":46876,"derivative":{"exercise_price":0,"expiration_date":"2020-12-16","underlying":"Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001562180-18-005027","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005027/primarydocument.xml","form_type":"4"}},{"id":3727424,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-18T19:48:29.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":678750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in four equal annual installments beginning on December 16, 2019."}],"balance_after":678750,"derivative":{"exercise_price":0,"expiration_date":"2028-12-16","underlying":"Common Stock","underlying_shares":678750},"source":{"system":"sec-edgar","filing":"0001562180-18-005027","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005027/primarydocument.xml","form_type":"4"}},{"id":3727423,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:48:29.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":113125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive once share of common stock. The RSUs vest and will be settled in common stock in four equal annual installments beginning on December 16, 2019."}],"balance_after":113125,"derivative":{"exercise_price":0,"expiration_date":"2022-12-20","underlying":"Common Stock","underlying_shares":113125},"source":{"system":"sec-edgar","filing":"0001562180-18-005027","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005027/primarydocument.xml","form_type":"4"}},{"id":3727422,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-18T19:48:29.000Z","date":"2018-12-16","kind":"tax_withholding","acquired":false,"shares":21303,"price":15.97,"value":340208.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":238709,"source":{"system":"sec-edgar","filing":"0001562180-18-005027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005027/primarydocument.xml","form_type":"4"}},{"id":3727421,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-18T19:48:29.000Z","date":"2018-12-16","kind":"exercise","acquired":true,"shares":48437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted on December 27, 2016 and December 16, 2017, as a result of the vesting of one fourth of such RSUs."}],"balance_after":260012,"source":{"system":"sec-edgar","filing":"0001562180-18-005027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005027/primarydocument.xml","form_type":"4"}},{"id":3880628,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"exercise","acquired":false,"shares":140625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest in four equal annual installments beginning on December 16, 2017."}],"balance_after":421875,"derivative":{"exercise_price":8.79,"expiration_date":"2026-12-27","underlying":"Common Stock","underlying_shares":140625},"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3880627,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"exercise","acquired":false,"shares":77881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs representing 77,881 shares of common stock vested upon the achievement of a second milestone relating to the return of rights to binimetinib to the Issuer on or prior to the fourth anniversary of the grant date, subject to continued service with the Issuer as of the vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2018-08-18","underlying":"Common Stock","underlying_shares":77881},"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3880626,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":140625,"price":18.03,"value":2535468.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $17.35 to $18.79. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":211575,"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3880625,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"exercise","acquired":true,"shares":140625,"price":8.79,"value":1236093.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares released on vesting of Restricted Stock Units (\"RSUs\") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II."}],"balance_after":352200,"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3880624,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":43628,"price":17.74,"value":773960.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $17.60 to $17.84. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":211575,"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3880623,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"tax_withholding","acquired":false,"shares":34253,"price":18.5,"value":633680.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":255203,"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3880622,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-06-29T16:22:11.000Z","date":"2018-06-27","kind":"exercise","acquired":true,"shares":77881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares released on vesting of Restricted Stock Units (\"RSUs\") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II."}],"balance_after":289456,"source":{"system":"sec-edgar","filing":"0001562180-18-003129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003129/primarydocument.xml","form_type":"4"}},{"id":3936958,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-12T01:11:31.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 4 equal quarterly installments following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-029725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919118029725/doc4.xml","form_type":"4"}},{"id":3936957,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-12T01:11:31.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6875,"source":{"system":"sec-edgar","filing":"0001209191-18-029725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454001/000120919118029725/doc4.xml","form_type":"4"}},{"id":3973808,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2018-04-03T18:48:47.000Z","date":"2018-04-01","kind":"exercise","acquired":false,"shares":18906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The remaining RSUs vest and will be settled in stock in two equal annual installments on April 1, 2019 and 2020."}],"balance_after":37813,"derivative":{"exercise_price":0,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":18906},"source":{"system":"sec-edgar","filing":"0001562180-18-001802","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001802/primarydocument.xml","form_type":"4"}},{"id":3973807,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-04-03T18:48:47.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":16605,"price":16.32,"value":270993.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":211575,"source":{"system":"sec-edgar","filing":"0001562180-18-001802","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001802/primarydocument.xml","form_type":"4"}},{"id":3973806,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-04-03T18:48:47.000Z","date":"2018-04-01","kind":"exercise","acquired":true,"shares":18906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by the Issuer on April 1, 2016 as a result of the vesting of one fourth of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 18,906 unvested Restricted Stock Units (\"RSUs\") awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs, and (ii) 18,906 shares of common stock issued upon the vesting of these RSU's on April 1, 2018."}],"balance_after":228180,"source":{"system":"sec-edgar","filing":"0001562180-18-001802","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001802/primarydocument.xml","form_type":"4"}},{"id":4126821,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"exercise","acquired":false,"shares":333165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The option vested in four equal annual installments beginning on May 3, 2014."}],"balance_after":0,"derivative":{"exercise_price":5.94,"expiration_date":"2023-05-03","underlying":"Common Stock","underlying_shares":333165},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126820,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"exercise","acquired":false,"shares":79688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The option vests in four equal annual installments beginning on April 1, 2015."}],"balance_after":345312,"derivative":{"exercise_price":4.63,"expiration_date":"2024-04-01","underlying":"Common Stock","underlying_shares":79688},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126819,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"exercise","acquired":false,"shares":133380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vested in four equal annual installments beginning on April 26, 2013."}],"balance_after":755820,"derivative":{"exercise_price":3.61,"expiration_date":"2022-04-26","underlying":"Common Stock","underlying_shares":133380},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126818,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":110800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vested in four equal annual installments beginning on April 26, 2013."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2022-04-26","underlying":"Common Stock","underlying_shares":110800},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126817,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":16835,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.94,"exercise_date":"2017-05-03","expiration_date":"2023-05-03","underlying":"Common Stock","underlying_shares":16835},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126816,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":226874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests in four equal annual installments beginning on April 1, 2016."}],"balance_after":226876,"derivative":{"exercise_price":7.3,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":226874},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126815,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-16","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests in four equal annual installments beginning on December 16, 2018."}],"balance_after":600000,"derivative":{"exercise_price":10.92,"expiration_date":"2027-12-16","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126814,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018."}],"balance_after":100000,"derivative":{"exercise_price":0,"expiration_date":"2021-12-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126813,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-16","kind":"exercise","acquired":false,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vested on December 16, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Consists of remaining unvested RSUs awarded to the reporting person for no additional cash consideration on December 16, 2016, which vest in three equal remaining installments beginning December 16, 2018, and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person."}],"balance_after":70313,"derivative":{"exercise_price":0,"expiration_date":"2020-12-16","underlying":"Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126812,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"sale","acquired":false,"shares":546233,"price":10.93,"value":5970326.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":209274,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126811,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"exercise","acquired":true,"shares":333165,"price":5.94,"value":1979000.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,812 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":755507,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126810,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"exercise","acquired":true,"shares":79688,"price":4.63,"value":368955.44,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,812 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":422342,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126809,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-19","kind":"exercise","acquired":true,"shares":133380,"price":3.61,"value":481501.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,812 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":342654,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126808,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"sale","acquired":false,"shares":273438,"price":10.73,"value":2933989.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":209274,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126807,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":110800,"price":3.61,"value":399988.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,812 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":482712,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126806,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":16835,"price":5.94,"value":99999.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,812 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":371912,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}},{"id":4126805,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":30346,"kind":"person","name":"Squarer Ron","position":1,"cik":"0001454001","reported_name":"Squarer Ron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-19T21:05:10.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":226874,"price":7.3,"value":1656180.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,812 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":355077,"source":{"system":"sec-edgar","filing":"0001562180-17-003955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003955/primarydocument.xml","form_type":"4"}}],"next_cursor":"2017-12-19T21:05:10.000000Z,4126805"}